These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19648195)

  • 1. National variation of ADHD diagnostic prevalence and medication use: health care providers and education policies.
    Fulton BD; Scheffler RM; Hinshaw SP; Levine P; Stone S; Brown TT; Modrek S
    Psychiatr Serv; 2009 Aug; 60(8):1075-83. PubMed ID: 19648195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
    Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK
    Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.
    Visser SN; Danielson ML; Bitsko RH; Holbrook JR; Kogan MD; Ghandour RM; Perou R; Blumberg SJ
    J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):34-46.e2. PubMed ID: 24342384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder.
    Walls M; Allen CG; Cabral H; Kazis LE; Bair-Merritt M
    Acad Pediatr; 2018 Apr; 18(3):256-265. PubMed ID: 29061327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State Variation in Increased ADHD Prevalence: Links to NCLB School Accountability and State Medication Laws.
    Fulton BD; Scheffler RM; Hinshaw SP
    Psychiatr Serv; 2015 Oct; 66(10):1074-82. PubMed ID: 26030315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic practices for attention deficit hyperactivity disorder: a national survey of primary care physicians.
    Chan E; Hopkins MR; Perrin JM; Herrerias C; Homer CJ
    Ambul Pediatr; 2005; 5(4):201-8. PubMed ID: 16026184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications.
    Bruckner TA; Hodgson A; Mahoney CB; Fulton BD; Levine P; Scheffler RM
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):442-9. PubMed ID: 22021031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in Rate of Attention-Deficit/Hyperactivity Disorder Management by Primary Care Providers.
    Bannett Y; Feldman HM; Bentley JP; Ansel DA; Wang CJ; Huffman LC
    Acad Pediatr; 2020 Apr; 20(3):384-390. PubMed ID: 31794864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient-centered medical home, practice patterns, and functional outcomes for children with attention deficit/hyperactivity disorder.
    Toomey SL; Chan E; Ratner JA; Schuster MA
    Acad Pediatr; 2011; 11(6):500-7. PubMed ID: 21967721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A National Profile of Attention-Deficit Hyperactivity Disorder Diagnosis and Treatment Among US Children Aged 2 to 5 Years.
    Danielson ML; Visser SN; Gleason MM; Peacock G; Claussen AH; Blumberg SJ
    J Dev Behav Pediatr; 2017 Sep; 38(7):455-464. PubMed ID: 28723824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of breast feeding and attention-deficit/hyperactivity disorder in United States preschool-aged children.
    Brasfield J; Goulding SM; Kancherla V
    Res Dev Disabil; 2021 Aug; 115():103995. PubMed ID: 34049210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-based and demographic variation in parent-reported medication rates for attention-deficit/hyperactivity disorder, 2007-2008.
    Visser SN; Blumberg SJ; Danielson ML; Bitsko RH; Kogan MD
    Prev Chronic Dis; 2013; 10():E09. PubMed ID: 23347704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-Level Estimates of the Prevalence of Parent-Reported ADHD Diagnosis and Treatment Among U.S. Children and Adolescents, 2016 to 2019.
    Danielson ML; Holbrook JR; Bitsko RH; Newsome K; Charania SN; McCord RF; Kogan MD; Blumberg SJ
    J Atten Disord; 2022 Nov; 26(13):1685-1697. PubMed ID: 35603751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.